Janssen Search
Search results
JAY P. SIEGEL, M.D.
Dr. Jay Siegel is Chief Biotechnology Officer and Head of Scientific Strategy and Policy, Johnson & Johnson. In these roles, he is actively engaged in research and development (R&D) leadership, and in policy development at the national and ...
Careers in Research & Development
Janssen Research & Development: Careers Our employees start each day with a new opportunity to transform healthcare and improve the quality of life for people in all corners of the world. We have made this our mission and our passion, and if you share ...
Gopi Shankar, M.B.A., Ph.D.
GOPI SHANKAR, M.B.A., PH.D. VICE PRESIDENT HEAD BIOLOGICS DEVELOPMENT SCIENCES Gopi Shankar, M.S., Ph.D., MBA, FAAPS, is Vice President and Head of Biologics Development Sciences (BDS) within Janssen BioTherapeutics (JBIO), Janssen Research & ...
Oncology Development Capabilities
Late Development: Delivering on Discovery’s Potential “When we see something special in oncology research, we will go the ends of the earth to get it done.” Craig Tendler, M.D. Vice President, Late Development and Global Medical Affairs Our world-class ...
The New Science of Cancer Interception
Thwarting Deadly Diseases Before They Start: The New Science of Cancer Interception Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she ...
Partner With Our Research & Development Team
Partner With Janssen Research & Development Collaboration is in our DNA. We know where it has taken us. We know it can take us further. With a rally cry as simple as "&." Collaborations A key element of our Janssen Research & ...
Research & Development: Accelerating the Molecule
Development Make research reality: accelerating molecule to medicine. At Janssen, we match cutting-edge science with world-class development and commercialization to bring treatment innovation to millions of patients suffering from cardiovascular, ...
Global Reach
Article Type: Infectious Diseases & Vaccines Global Reach We seek opportunities to combine our scientific capabilities with world-class innovation from government, industry and academia to speed up the development of solutions that will combat the ...
Frank de Wolf, M.D., PH.D.
As Global Head of the Janssen Prevention Center, Frank de Wolf is responsible for driving research to develop new concepts for disease prevention that will extend the healthy life span. He was appointed to this position in March 2017. Frank has been Head ...
Our Fight Against Alzheimer’s
Our Fight Against Alzheimer’s September is World Alzheimer’s Month, a tradition that began in 2012 to draw attention to this devastating brain disease. It is easy to get discouraged about Alzheimer’s. Worldwide, nearly 44 million people have Alzheimer’s ...